Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude
Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease
Objective: To delineate the age-associated changes in microglial morphotypes in the substantia nigra pars compacta (SNpc) of C57BL/6J and CD-1 mice and alterations in response…The role of pathology validation on the association between smoking and Parkinson’s Disease
Objective: The aim of this study is to investigate the relationship between smoking and Parkinson’s disease in pathology validated Parkinson’s disease patients. Background: Literature has…Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19
Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: In the scientific literature, there is information about the…Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients
Objective: To define the mechanism of Osteopathic Manipulative Treatment (OMT) in decreasing symptomology and improving gait in Parkinson’s Disease (PD) patients. Background: A key symptom…Investigating Interrater Reliability of the Unified Huntington’s Disease Rating Scale Motor Component Between Learner and Experienced Rater
Objective: The aim of this project is to explore the interrater reliability of the standardized motor exam of the Unified Huntington’s Disease Rating Scale (UHDRS)…Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review
Objective: To evaluate the cost-effectiveness of Botulinum Toxin A in our movement disorder division. Background: Botulinum Toxin A is an FDA-approved treatment for various medical…Patient and Caregiver Experiences with Tardive Dyskinesia: Emotions, Challenges, and Unmet Needs in the Patient Journey
Objective: To describe the emotional journey from symptom onset to current state and identify challenges and unmet needs of participants living with tardive dyskinesia (TD)…Triple threat: A rare case of a patient with 3 co-existent autoimmune antibodies causing autonomic and movement disorder
Objective: We describe a unique case of a patient with a constellation of movement and autonomic abnormalities. Serum paraneoplastic/autoimmune testing was positive for 3 separate…Role of the Alpha-synuclein Seed Amplification Assay in Parkinson’s Disease Clinical Trials: A Case Report of Multiple System Atrophy Misdiagnosed as Parkinson’s Disease
Objective: Report a patient with Multiple System Atrophy (MSA) misdiagnosed as Parkinson’s disease (PD) and enrolled in a clinical trial for PD treatment with Mesenchymal…
- « Previous Page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- …
- 181
- Next Page »